PLIANT THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
PLIANT THERAPEUTICS, INC. (PLRX) reported Basic Shares Outstanding (Weighted Average) of 61.92 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 61.92M shares, a 0.87% increase year-over-year.
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 61.80M shares, a 0.95% increase year-over-year.
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 61.45M shares, a 0.98% increase year-over-year.
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 61.41M shares, a 1.11% increase year-over-year.
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 61.37M shares, a 1.37% increase from fiscal 2024.
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 60.54M shares, a 3.10% increase from fiscal 2023.
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 58.72M shares, a 39.75% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 42.02M shares, a 17.21% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 61.92M shares 10-Q · filed 2026-08-11 | 61.86M shares 10-Q · filed 2026-08-11 | 61.72M shares derived: average of 3 quarters · filed 2026-08-11 | 61.64M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 61.80M shares 10-Q · filed 2026-05-11 | 61.63M shares derived: average of 2 quarters · filed 2026-05-11 | 61.55M shares derived: average of 3 quarters · filed 2026-05-11 | 61.51M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 61.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 61.43M shares derived: average of 2 quarters · filed 2026-03-11 | 61.41M shares derived: average of 3 quarters · filed 2026-08-11 | 61.37M shares 10-K · filed 2026-03-11 |
| 2025-09-30 | 61.41M shares 10-Q · filed 2025-11-06 | 61.40M shares derived: average of 2 quarters · filed 2026-08-11 | 61.34M shares 10-Q · filed 2025-11-06 | 61.22M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 61.39M shares 10-Q · filed 2026-08-11 | 61.30M shares 10-Q · filed 2026-08-11 | 61.16M shares derived: average of 3 quarters · filed 2026-08-11 | 61.05M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 61.22M shares 10-Q · filed 2026-05-11 | 61.04M shares derived: average of 2 quarters · filed 2026-05-11 | 60.94M shares derived: average of 3 quarters · filed 2026-05-11 | 60.80M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 60.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 60.79M shares derived: average of 2 quarters · filed 2026-03-11 | 60.66M shares derived: average of 3 quarters · filed 2026-03-11 | 60.54M shares 10-K · filed 2026-03-11 |
| 2024-09-30 | 60.73M shares 10-Q · filed 2025-11-06 | 60.56M shares derived: average of 2 quarters · filed 2025-11-06 | 60.43M shares 10-Q · filed 2025-11-06 | 60.30M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 60.38M shares 10-Q · filed 2025-08-07 | 60.28M shares 10-Q · filed 2025-08-07 | 60.16M shares derived: average of 3 quarters · filed 2025-08-07 | 60.04M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 60.18M shares 10-Q · filed 2025-05-08 | 60.05M shares derived: average of 2 quarters · filed 2025-05-08 | 59.93M shares derived: average of 3 quarters · filed 2025-05-08 | 59.74M shares derived: average of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 59.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 59.80M shares derived: average of 2 quarters · filed 2025-03-03 | 59.59M shares derived: average of 3 quarters · filed 2025-03-03 | 58.72M shares 10-K · filed 2025-03-03 |
| 2023-09-30 | 59.69M shares 10-Q · filed 2024-11-07 | 59.43M shares derived: average of 2 quarters · filed 2024-11-07 | 58.32M shares 10-Q · filed 2024-11-07 | 55.94M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | 59.17M shares 10-Q · filed 2024-08-07 | 57.62M shares 10-Q · filed 2024-08-07 | 54.70M shares derived: average of 3 quarters · filed 2025-03-03 | 52.72M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | 56.06M shares 10-Q · filed 2024-05-06 | 52.46M shares derived: average of 2 quarters · filed 2025-03-03 | 50.57M shares derived: average of 3 quarters · filed 2025-03-03 | 46.97M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | 48.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 47.83M shares derived: average of 2 quarters · filed 2025-03-03 | 43.94M shares derived: average of 3 quarters · filed 2025-03-03 | 42.02M shares 10-K · filed 2025-03-03 |
| 2022-09-30 | 46.80M shares 10-Q · filed 2023-11-09 | 41.49M shares derived: average of 2 quarters · filed 2023-11-09 | 39.74M shares 10-Q · filed 2023-11-09 | 38.78M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 36.17M shares 10-Q · filed 2023-08-09 | 36.14M shares 10-Q · filed 2023-08-09 | 36.10M shares derived: average of 3 quarters · filed 2024-02-27 | 36.06M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 36.12M shares 10-Q · filed 2023-05-09 | 36.07M shares derived: average of 2 quarters · filed 2024-02-27 | 36.02M shares derived: average of 3 quarters · filed 2024-02-27 | 35.95M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 36.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 35.97M shares derived: average of 2 quarters · filed 2024-02-27 | 35.89M shares derived: average of 3 quarters · filed 2024-02-27 | 35.85M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 35.91M shares 10-Q · filed 2022-11-08 | 35.83M shares derived: average of 2 quarters · filed 2022-11-08 | 35.79M shares 10-Q · filed 2022-11-08 | 35.72M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 35.75M shares 10-Q · filed 2022-08-08 | 35.73M shares 10-Q · filed 2022-08-08 | 35.66M shares derived: average of 3 quarters · filed 2022-08-08 | 35.61M shares derived: average of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | 35.65M shares 10-Q · filed 2022-05-09 | 35.62M shares derived: average of 2 quarters · filed 2022-05-09 | 35.56M shares derived: average of 3 quarters · filed 2022-05-09 | 29.74M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 35.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 35.52M shares derived: average of 2 quarters · filed 2022-03-01 | 27.77M shares derived: average of 3 quarters · filed 2022-03-01 | 21.34M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 35.45M shares 10-Q · filed 2021-11-09 | 23.85M shares derived: average of 2 quarters · filed 2021-11-09 | 16.59M shares 10-Q · filed 2021-11-09 | 12.85M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | 12.25M shares 10-Q · filed 2021-08-09 | 7.06M shares 10-Q · filed 2021-08-09 | 5.32M shares derived: average of 3 quarters · filed 2022-03-01 | 4.42M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | 1.90M shares 10-Q · filed 2021-05-10 | 1.85M shares derived: average of 2 quarters · filed 2022-03-01 | 1.81M shares derived: average of 3 quarters · filed 2022-03-01 | 1.75M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | 1.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.76M shares derived: average of 2 quarters · filed 2022-03-01 | 1.69M shares derived: average of 3 quarters · filed 2022-03-01 | 1.62M shares 10-K · filed 2022-03-01 |
| 2019-09-30 | 1.71M shares 10-Q · filed 2020-11-10 | 1.64M shares derived: average of 2 quarters · filed 2020-11-10 | 1.56M shares 10-Q · filed 2020-11-10 | |
| 2019-06-30 | 1.56M shares 10-Q · filed 2020-08-11 | 1.49M shares 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |